Based on the SMILES Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1, the molecule has a half life in humans after IV administration of 1.000 hours.
Based on the {SMILES__description} {#representation |!}{SMILES#}, the molecule has a {half_life_duration__names__noun} of {half_life_duration#} {half_life_duration__units}.
1H-benzimidazol-2-yl-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]-oxidosulfanium